Karen Larochelle
Venture Partner and Board Director
Philadelphia, Pennsylvania
Overview
Work Experience
Global Head of Business Strategy and Portfolio Innovation
2025 - Current
Board Member
2020 - 2025
Audit and Compensation Committee member
PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.
Raised $30,680,000.00 from The Lind Partners.
Consulting Chief Business Officer to multiple biotechs
2013 - 2025
Fractional consulting CBO focused on strategy, Business Development and financing.
Operational Partner
2020 - 2023
SVP, Corporate and Business Development
2020 - 2021
WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
Raised $42,500,000.00 from Medivate Partners, Camden Partners, Domain Associates, Qiming Venture Partners and FoxKiser.
Chief Business Officer
2016 - 2019
Global Business Development & Head of China Business Development
1993 - 2013
Executive Director, Business Development 2006-2013 Head of China Business Development 2010-2013 Director, Business Development 2000-2006 Associate Director, International Finance 1999-2000 Manager, Business Analysis 1995-1999 Financial Associate (MBA rotational program) 1993-1995
Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
Raised $23,580,000,000.00 from RA Capital Management, OUP (Osage University Partners), Aperture Venture Partners, Greg Bailey, Connecticut Innovations, Knoll Capital Management, Vivo Capital, Venrock, Litmore Capital and Carl Icahn.
Consultant
1988 - 1991